The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells

β-thalassemia, a disease that results from defects in β-globin synthesis, leads to an imbalance of β- and α-globin chains and an excess of α chains. Defective erythroid maturation, ineffective erythropoiesis, and shortened red blood cell survival are commonly observed in most β-thalassemia patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Rattananon, Parin, Anurathapan, Usanarat, Bhukhai, Kanit, Hongeng, Suradej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517149/
https://www.ncbi.nlm.nih.gov/pubmed/34658870
http://dx.doi.org/10.3389/fphar.2021.730873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517149/
https://www.ncbi.nlm.nih.gov/pubmed/34658870
http://dx.doi.org/10.3389/fphar.2021.730873

Ejemplares similares